Company Overview

Curaleaf Holdings, Inc. is a vertically integrated cannabis company operating in the cannabis cultivation, processing, wholesale, and retail industries. The company focuses on producing and distributing medical and adult-use cannabis products, with revenue primarily generated through retail dispensary sales and wholesale distribution of branded cannabis products. Curaleaf serves regulated cannabis markets, targeting medical patients and adult-use consumers through a multi-brand portfolio and large-scale retail footprint.

The company is positioned as one of the largest cannabis operators in the United States by revenue, with strategic advantages that include vertical integration, national brand development, and early entry into limited-license markets. Curaleaf was founded in the early 2010s and evolved rapidly through organic expansion and acquisitions, consolidating assets under the Curaleaf brand following its public listing and becoming a prominent multi-state operator (MSO) in the U.S. cannabis sector.

Business Operations

Curaleaf operates through integrated business lines encompassing retail dispensaries, cultivation facilities, and processing and manufacturing operations. The company generates revenue through direct-to-consumer sales at company-owned dispensaries and through wholesale distribution of cannabis flower and derivative products to third-party retailers. Its branded product portfolio includes Select, Grassroots, and Curaleaf, which span multiple product categories such as vape products, edibles, oils, and flower.

Operations are primarily concentrated in the United States, supported by a network of cultivation and processing assets designed to supply state-level markets in compliance with local regulations. Internationally, Curaleaf operates through Curaleaf International, which manages medical cannabis cultivation, manufacturing, and distribution in select European markets. The company controls proprietary cultivation genetics, manufacturing processes, and retail operations, enabling quality control and margin optimization.

Strategic Position & Investments

Curaleaf’s strategy centers on disciplined growth in high-population, limited-license jurisdictions, operational efficiency, and brand expansion. The company has historically pursued growth through acquisitions of licensed operators and assets, integrating them into its vertically integrated platform while rationalizing costs. Major past acquisitions have included Grassroots Cannabis, which expanded Curaleaf’s wholesale and retail presence across multiple U.S. states.

The company continues to invest in product innovation, selective capital expenditures, and international medical cannabis markets, particularly in Europe. Emerging focus areas include pharmaceutical-grade medical cannabis, expansion of high-margin derivative products, and operational optimization rather than aggressive large-scale acquisitions. Curaleaf maintains a portfolio of subsidiaries aligned with its U.S. and international operations, with investment activity shaped by evolving regulatory conditions.

Geographic Footprint

Curaleaf is headquartered in the United States, with its principal executive offices in New York. The company operates across numerous U.S. states, including major markets in the Northeast, Midwest, South, and Western United States, giving it one of the broadest geographic footprints among U.S. cannabis operators.

Internationally, Curaleaf has an established presence in Europe, with operations and investments in countries such as the United Kingdom, Germany, and Portugal through Curaleaf International. These operations focus on medical cannabis cultivation, manufacturing, and distribution, positioning the company to participate in the gradual expansion of regulated cannabis markets outside the U.S.

Leadership & Governance

Curaleaf was co-founded by Boris Jordan, who has played a central role in shaping the company’s strategy and growth. Leadership emphasizes scale, regulatory compliance, and long-term positioning ahead of broader cannabis legalization trends. The governance structure includes an experienced executive team with backgrounds in finance, consumer products, healthcare, and regulated industries.

Key executives include:

• Boris Jordan – Executive Chairman
• Matt Darin – Chief Executive Officer
• Igor Zolotarev – Chief Financial Officer

The leadership team’s strategic vision focuses on sustainable profitability, disciplined capital allocation, and building nationally recognized cannabis brands while navigating complex regulatory environments.